Long-term safety of orbital radiotherapy for Graves' ophthalmopathy

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 8, 2003, Pages 3561-3566

  Marcocci, Claudio ^a   Bartalena, Luigi ^b   Rocchi, Roberto ^a   Marinò, Michele ^a   Menconi, Francesca ^a   Morabito, Eugenia ^a   Mazzi, Barbara ^a   Mazzeo, Salvatore ^a   Sartini, Maria Sole ^a   Nardi, Marco ^a   Cartei, Francesco ^c   Cionini, Luca ^a   Pinchera, Aldo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ADULT; ARTICLE; COBALT THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; EYE DISEASE; FEMALE; GRAVES DISEASE; HUMAN; HYPERTENSION; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RADIATION CATARACT; RADIATION DOSE; RADIATION FIELD; RETINOPATHY; SAFETY; TREATMENT CONTRAINDICATION;

ADOLESCENT; ADULT; AGED; CATARACT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; ITALY; MALE; MIDDLE AGED; ORBIT; PARANASAL SINUS DISEASES; RADIOTHERAPY; RETINAL DISEASES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0042885667     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030260     Document Type: Article

References (30)

1. Bartalena L, Pinchera A, Marcocci C 2000 Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 21:168-199
2. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A 2001 Comparison of the effectiveness and tolerability of intravenous and oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab 86:3562-3567
3. Bartalena L, Marcocci C, Tanda ML, Rocchi R, Mazzi B, Barbesino G, Pinchera A 2002 Orbital radiotherapy for Graves' ophthalmopathy. Thyroid 12:245-250
4. Garrity JA, Fatourechi V, Bergstralh EJ, Bartley GB, Beatty CW, DeSanto LW, Gorman CA 1993 Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy. Am J Ophthalmol 116:533-547
5. Bartalena L, Marcocci C, Pinchera A 1997 Treating severe Graves' ophthalmopathy. Bailliere Clin Endocrinol Metab 11:521-536
6. Wiersinga WM, Prummel MF 2002 Graves' ophthalmopathy: a rational approach to treatment. Trends Endocrinol Metab 13:280-287
7. Pinchera A, Bartalena L, Chiovato L, Marcocci C 1984 Radiotherapy of Graves' ophthalmopathy. In: Gorman CA, Waller RR, Dyer JA eds. The eye and orbit in thyroid diseases. New York: Raven Press; 301-316
8. Bartalena L, Marcocci C, Chiovato L, Laddaga M, Lepri G, Andreani D, Cavallacci G, Baschieri L, Pinchera A 1983 Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 56:1139-1144
9. Snijders-Keilholz A, De Keizer RJW, Goslings BM, Van Dam EWCM, Jansen JThM, Broerse JJ 1996 Probable risk of tumor induction after retroorbital irradiation for Graves' ophthalmopathy. Radiother Oncol 38:69-71
10. Blank LECM, Barendsen GW, Prummel MF, Stalpers L, Wiersinga WM, Koornneel L 1996 Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy. Radiother Oncol 40:187-188
11. Giuffré G, Giammanco R, Di Pace F, Ponte F 1995 Casteldaccia eye study: prevalence of cataract in the adult and elderly population of a Mediterranean town. Int Ophthalm 18:363-371
12. Leer JWH, van Houtte P, Davelaar J 1998 Indications and treatment schedules for irradiation of benign diseases: a survey. Radiother Oncol 48:249-257
13. Bartalena L, Marcocci C, Gorman CA, Wiersinga WM, Pinchera A 2003 Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous. J Endocrinol Invest 26:5-16
14. Mourits MP, van Kempen-Harteveld ML, Garcia MB, Koppeschaar HP, Tick L, Terwee CB 2000 Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study. Lancet 355:1505-1509
15. Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB 2001 A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 108:1523-1534
16. Beckendorf V, Maalouf T, George J-L, Bey P, Leclere J, Luporsi E 1999 Place of radiotherapy in the treatment of Graves' orbitopathy. Int J Radiat Oncol Biol Phys 43:805-815
17. Petersen YA, Kriss JP, McDougall IR, Donaldson SS 1994 Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 19:259-264
18. Marquez SD, Lum BL, McDougall IR, Katkuri S, Levin PS, MacManus PS, Donaldson SS 2001 Long-term results of irradiation for patients with Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 51:766-774
19. Klein BE, Klein R 1982 Cataracts and macular degeneration in older Americans. Arch Ophthalmol 100:571-573
20. Parker RG, Withers HR 1988 Radiation retinopathy. JAMA 259:43
21. Merriam GR, Focht EF 1957 A clinical study of radiation cataract and the relationship to dose. Am J Roentgenol 77:759-785
22. Viebahn M, Marricks ME, Osterloh MD 1991 Synergism between diabetic and radiation retinopathy: case report and review. Br J Ophthalmol 75:29-32
23. Miller ML, Goldberg SH, Bullock JD 1991 Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy. Int J Radiat Oncol Biol Phys 19:259-264
24. Kinyoun JL, Kalina RE, Brower SA, Mills RP, Johnson RH 1984 Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy. Arch Ophthalmol 102:1473-1476
25. Wakelkamp JMM, Tan H, Saeed P, Schlingemann RO, Verbraak FD, Smet de MD, Blank LEC, Prummel M 2002 Is retrobulbar irradiation safe in the long run? The Amsterdam Graves' ophthalmopathy (GO) follow-up study. J Endocrinol Invest 25(Suppl):7 (Abstract)
26. Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Buettner H, Robertson DM, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB 2002 The aftermath of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 109:2100-2107
27. Boerse JJ, Snijders-Keilholz A, Jensen JT, Zoetelief J, Klein C, Seegenschmiedt MH 1999 Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry. Radiother Oncol 53:205-208
28. Schaefer U, Hesselmann S, Micke O, Schueller Bruns F, Palma C, Willich N 2002 A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 52:192-197
29. Chang C-C, Chen M-K, Wen Y-S, Lee H-S, Wu H-K, Liu M-T 2000 Effects of radiotherapy for nasopharyngeal carcinoma on the paranasal sinuses: Study based on computed tomography scanning. J Otolaryngol 29:23-27
30. Havas TE, Motbey JA, Gullane PJ 1988 Prevalence of incidental abnormalities on computed tomographic scans of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 114:856-859